FdaApplication
NDA 212854
Identifiers
- fda_app_no: NDA212854
Properties
| Property | Value |
|---|---|
| applicant_name | ZMI PHARMA INC |
| application_type | NDA |
| approval_date | 2021-10-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZIMHI | NALOXONE HYDROCHLORIDE | 5MG/0.5ML (5MG/0.5ML) | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS |
1 product